Alpha 2.0
Login Register
» Articles » PMID: 36201019

Molecular and Clinicopathologic Characteristics of Gliomas with EP300::BCOR Fusions

Overview
Journal Acta Neuropathol
Specialty Neurology
Date 2022 Oct 6
PMID 36201019
Authors
Zhichao Wu
Sharika Rajan
Hye-Jung Chung
Mark Raffeld
Pavalan Panneer Selvam
Leonille Schweizer
Arie Perry
David Samuel
Caterina Giannini
Aditya Ragunathan
Matthew P Frosch
Michael S Marshall
Daniel R Boue
Kliment Donev
Stewart G Neill
Igor Fernandes
Adam Resnick
Brian Rood
Thomas J Cummings
Anne F Buckley
Linda Szymanski
Osorio Lopes Abath Neto
Leor Zach
Howard Colman
Samuel Cheshier
Jennifer Ziskin
Manoj Tyagi
David Capper
Zied Abdullaev
Patrick J Cimino
Martha Quezado
Drew Pratt
Kenneth Aldape
Affiliations
Soon will be listed here.
Citing Articles

A novel KDM2A::YAP1 fusion in a pediatric supratentorial CNS neoplasm resembling a tumor with BCOR internal tandem duplication.

Tauziede-Espariat A, Metais A, Bochaton D, Servant E, Chotard G, Le Quang M Free Neuropathol. 2025; 6:5.

PMID: 40012953 PMC: 11862909. DOI: 10.17879/freeneuropathology-2025-6152.

cIMPACT-NOW update 9: Recommendations on utilization of genome-wide DNA methylation profiling for central nervous system tumor diagnostics.

Aldape K, Capper D, von Deimling A, Giannini C, Gilbert M, Hawkins C Neurooncol Adv. 2025; 7(1):vdae228.

PMID: 39902391 PMC: 11788596. DOI: 10.1093/noajnl/vdae228.

BCOR::CREBBP fusion in malignant neuroepithelial tumor of CNS expands the spectrum of methylation class CNS tumor with BCOR/BCOR(L1)-fusion.

Ebrahimi A, Waha A, Schittenhelm J, Gohla G, Schuhmann M, Pietsch T Acta Neuropathol Commun. 2024; 12(1):60.

PMID: 38637838 PMC: 11025138. DOI: 10.1186/s40478-024-01780-5.

CNS tumor with CREBBP::BCORL1 Fusion and pathogenic mutations in BCOR and CREBBP: expanding the spectrum of BCOR-altered tumors.

Barresi V, Cardoni A, Miele E, Pedace L, Masotto B, Nardini C Acta Neuropathol Commun. 2024; 12(1):8.

PMID: 38216991 PMC: 10785472. DOI: 10.1186/s40478-024-01726-x.

Pediatric diffuse glioma with EP300::BCOR fusion manifesting as low-grade epilepsy-associated neuroepithelial tumor: a case presentation.

Nakata S, Arai Y, Fukuoka K, Shirakura T, Yamazaki A, Osawa S Brain Tumor Pathol. 2023; 41(1):35-39.

PMID: 38133797 DOI: 10.1007/s10014-023-00475-4.

References
1.
Yamazaki A, Arai Y, Fukuoka K, Nakano Y, Hama N, Nakata S . Diffusely infiltrating glioma with CREBBP-BCORL1 fusion showing overexpression of not only BCORL1 but BCOR: A case report. Brain Tumor Pathol. 2022; 39(3):171-178. DOI: 10.1007/s10014-022-00435-4. View
2.
Sturm D, Orr B, Toprak U, Hovestadt V, Jones D, Capper D . New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs. Cell. 2016; 164(5):1060-1072. PMC: 5139621. DOI: 10.1016/j.cell.2016.01.015. View
3.
Mermel C, Schumacher S, Hill B, Meyerson M, Beroukhim R, Getz G . GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 2011; 12(4):R41. PMC: 3218867. DOI: 10.1186/gb-2011-12-4-r41. View
4.
Torre M, Meredith D, Dubuc A, Solomon D, Perry A, Vasudevaraja V . Recurrent EP300-BCOR Fusions in Pediatric Gliomas With Distinct Clinicopathologic Features. J Neuropathol Exp Neurol. 2019; 78(4):305-314. DOI: 10.1093/jnen/nlz011. View
5.
de Lima L, Surme M, Gessi M, Mastronuzzi A, Miele E, Tamburrini G . Central nervous system high-grade neuroepithelial tumor with BCOR alteration (CNS HGNET-BCOR)-case-based reviews. Childs Nerv Syst. 2020; 36(8):1589-1599. DOI: 10.1007/s00381-020-04692-6. View